Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate

被引:25
作者
Chung, F. S. [1 ]
Eyal, S. [1 ]
Muzi, M. [2 ]
Link, J. M. [2 ]
Mankoff, D. A. [2 ]
Kaddoumi, A. [1 ]
O'Sullivan, F. [3 ]
Hsiao, P. [1 ]
Unadkat, J. D. [1 ]
机构
[1] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[2] Univ Washington, Div Nucl Med, Seattle, WA 98195 USA
[3] Univ Coll Cork, Sch Math Sci, Cork, Ireland
关键词
ABCB1; (MDR1; P-glycoprotein); C-11-verapamil; blood-brain barrier; pregnancy; non-human primates; BLOOD-BRAIN-BARRIER; IN-VIVO; MULTIDRUG-RESISTANCE; HUMAN PLACENTA; MACACA-NEMESTRINA; DRUG-INTERACTIONS; GESTATIONAL AGES; COMBINED PET; INHIBITION; EXPRESSION;
D O I
10.1111/j.1476-5381.2009.00538.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Changes in tissue P-glycoprotein (P-gp) activity during pregnancy could affect the pharmacokinetics and thus the efficacy and toxicity of many drugs. Therefore, using positron emission tomography (PET) imaging, we tested whether gestational age affects tissue P-gp activity in the pregnant non-human primate, Macaca nemestrina. Experimental approach: Mid-gestational (day 75 +/- 13, n = 7) and late-gestational (day 150 +/- 10, n = 5) age macaques were imaged after administration of a prototypic P-gp substrate, C-11-verapamil (13.7-75.4 MBq.kg(-1)), before and during intravenous infusion of a P-gp inhibitor, cyclosporin A (CsA) (12 or 24 mg.kg(-1).h(-1)). Accumulation of radioactivity in the fetal liver served as a reporter of placental P-gp activity. P-gp activity was expressed as CsA-induced percent change in the ratio of the area (0-9 min) under the C-11-radioactivity concentration-time curve in the tissue (AUC(tissue)) to that in the maternal plasma (AUC(plasma)). Key results: The CsA-induced change in AUC(fetal) (liver)/AUC(maternal) (plasma) of C-11-radioactivity significantly increased from mid- (35 +/- 25%) to late gestation (125 +/- 66%). Likewise, the CsA-induced change in AUC(maternal) (brain)/AUC(plasma) increased from mid- (172 +/- 80%) to late gestation (337 +/- 148%). The AUC ratio for the other maternal tissues was not significantly affected. Neither the CsA blood concentrations nor the level of circulating C-11-verapamil metabolites were significantly affected by gestational age. Conclusions and implications: P-gp activity at the blood-brain barrier and the placental barrier in the macaque increased with gestational age. If replicated in humans, the exposure of the fetus and maternal brain to P-gp substrate drugs, and therefore their efficacy and toxicity, will change during pregnancy. British Journal of Pharmacology (2010) 159, 394-404; doi:10.1111/j.1476-5381.2009.00538.x; published online 4 December 2009
引用
收藏
页码:394 / 404
页数:11
相关论文
共 41 条
  • [1] Guide to receptors and channels (GRAC), 3rd edition
    Alexander, Stephen P. H.
    Mathie, Alistair
    Peters, John A.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 : S1 - S209
  • [2] Altman P. L., 1974, BIOL DATA BOOK
  • [3] [Anonymous], 2005, WILLIAMS OBSTET
  • [4] Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET
    Bart, J
    Willemsen, ATM
    Groen, HJM
    van der Graaf, WTA
    Wegman, TD
    Vaalburg, W
    de Vries, EGE
    Hendrikse, NH
    [J]. NEUROIMAGE, 2003, 20 (03) : 1775 - 1782
  • [5] Benveniste H, 2005, J NUCL MED, V46, P312
  • [6] Benveniste H, 2003, J NUCL MED, V44, P1522
  • [7] P-glycoprotein in the placenta: Expression, localization, regulation and function
    Ceckova-Novotna, Martina
    Pavek, Petr
    Staud, Frantisek
    [J]. REPRODUCTIVE TOXICOLOGY, 2006, 22 (03) : 400 - 410
  • [8] Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier
    Choo, Edna F.
    Kurnik, Daniel
    Muszkat, Mordechai
    Ohkubo, Tadashi
    Shay, Sheila D.
    Higginbotham, James N.
    Glaeser, Hartmut
    Kim, Richard B.
    Wood, Alastair J. J.
    Wilkinson, Grant R.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (03) : 1012 - 1018
  • [9] PRODUCTION OF ULTRA HIGH ACTIVITY C-11-LABELED HYDROGEN-CYANIDE, CARBON-DIOXIDE, CARBON-MONOXIDE AND METHANE VIA N-14(RHO,ALPHA)C-11 REACTION .15.
    CHRISTMAN, DR
    FINN, RD
    KARLSTROM, KI
    WOLF, AP
    [J]. INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1975, 26 (08): : 435 - 442
  • [10] CLARK JC, 1975, SHORT LIVED RADIOACT, P150